Indaptus Therapeutics Inc...

NASDAQ: INDP · Real-Time Price · USD
7.58
-0.23 (-2.94%)
At close: Aug 15, 2025, 3:59 PM
7.30
-3.69%
After-hours: Aug 15, 2025, 05:43 PM EDT

Indaptus Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
6.16M 3.89M 5.79M 7.38M 7.3M 9.74M 13.36M 15.96M 12.7M 6.81M 9.63M 6.72M 14.26M 33.22M 39.13M 41.86M 16.99M 4.49M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a 6.99M 14.88M 16.81M 21.74M 18.75M 2.96M n/a 44.45K n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
392.57K 392.57K 638.25K 504.73K 504.73K 504.73K 754.73K 754.73K 754.73K 754.73K 738.25K 754.73K 659.05K 16.48K 16.48K n/a 1.3M 44.45K
Receivables
n/a n/a n/a n/a n/a n/a n/a n/a n/a 19.06K n/a n/a n/a n/a 21.06K n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a -19.06K n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
255.36K n/a n/a n/a n/a 114.75K n/a n/a 32.1K n/a 80.91K 248.72K 69.23K 78.35K 148.4K 644.45K 1M 801.34K
Total Current Assets
6.41M 4.96M 6.62M 7.63M 7.49M 10.29M 14M 16.84M 19.87M 22.15M 27.24M 29.59M 33.27M 36.92M 40.39M 43.85M 18.79M 5.3M
Property-Plant & Equipment
33.58K 58.12K 82.17K 105.66K 128.63K 151.12K 173.94K 195.81K 217.22K 238.2K 81.31K 104.59K 127.58K 150.37K 172.89K 4.33K 3.12K 1.14K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
426.15K 450.69K 720.43K 610.38K 633.36K 655.85K 928.67K 950.53K 971.95K 992.93K 819.56K 859.32K 786.63K 166.84K 189.37K 4.33K 1.3M 45.58K
Total Assets
6.84M 5.41M 7.34M 8.24M 8.12M 10.95M 14.92M 17.79M 20.84M 23.14M 28.06M 30.45M 34.06M 37.09M 40.58M 43.86M 20.09M 5.34M
Account Payables
n/a 1.31M 870.23K 555.95K 416.56K 405.46K 806K 617.27K 747.67K 382.1K 1.38M 1.25M 2.43M 2.83M 2.64M 3.34M 397K 75.56K
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a -747.67K -1.72M n/a n/a -97.91K n/a n/a n/a n/a -581K
Short-Term Debt
34.37K n/a 84.16K 103.98K 103.22K 102.46K 101.7K 101K 100.42K n/a 80.49K 98.63K 97.91K 97.19K n/a n/a n/a n/a
Other Current Liabilities
8.48M 83.47K 1.29M 835.8K 576.12K 434.71K 1.11M -101K 595.87K 910.52K 1.26M 789.45K 489.42K 374.32K 498.73K 0.00 4.58M 5.74M
Total Current Liabilities
8.51M 2.61M 3.39M 2.23M 1.93M 1.54M 2.77M 2.37M 2.1M 1.82M 3.43M 2.88M 3.62M 3.68M 4.6M 5.78M 5.44M 6.17M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 178K
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 716K 527K
Total Long-Term Liabilities
n/a n/a n/a 4.01K 27.58K 50.66K 73.35K 95.24K 116.17K 136.67K 1.46M 4.95K 27.91K 50.52K 72.86K n/a 716K 883K
Total Liabilities
8.51M 2.61M 3.39M 2.24M 1.96M 1.59M 2.85M 2.46M 2.22M 1.96M 3.43M 2.89M 3.65M 3.73M 4.68M 5.78M 6.16M 6.17M
Total Debt
34.37K 59.51K 84.16K 107.99K 130.8K 153.13K 175.05K 196.24K 216.59K 236.51K 80.49K 103.57K 125.81K 147.7K 169.33K n/a 630K 178K
Common Stock
6.05K 160.34K 120.14K 101.97K 85.53K 85.39K 84.01K 84.01K 84.01K 84.01K 84.01K 82.59K 82.59K 82.59K 82.59K 81.33K 727K 733.00
Retained Earnings
-70.2M -64.97M -60.44M -56.31M -53.24M -49.22M -45.42M -41.41M -37.49M -34.25M -29.99M -26.34M -22.87M -19.04M -15.67M -12.45M -215.21M -8.57M
Comprehensive Income
n/a n/a n/a n/a n/a n/a n/a n/a 134.16K 177.46K 96.43K 15.13K -26.94K -9.22K n/a -0.00 -315 0.00
Shareholders Equity
-1.67M 2.8M 3.94M 6M 6.17M 9.36M 12.08M 15.33M 18.63M 21.19M 24.63M 27.57M 30.41M 33.36M 35.9M 38.08M 13.94M -829.68K
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a 6.99M 14.88M 16.81M 21.74M 18.75M 2.96M n/a 44.45K n/a n/a